DRISCOLL FREDERICK W
SEC insider (Form 3/4/5 filer). CIK 0001129890. Director at Lite Strategy, Inc. (LITS) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in SAN DIEGO, CA.
Companies DRISCOLL FREDERICK W has filed insider reports for
- Lite Strategy, Inc. (LITS): Director
- Cellectar Biosciences, Inc. (CLRB): Director
- Cue Biopharma, Inc. (CUE): Director
DRISCOLL FREDERICK W
CIK: 0001129890
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 22, 2026LITS
Lite Strategy, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Jul 7, 2026CLRB
Cellectar Biosciences, Inc.
AwardDirectStock option (right to buy)
25K shares- - Nov 14, 2025LITS
Lite Strategy, Inc.
AwardDirectStock Option (Right to Buy)
55K shares- - Jul 15, 2025MEIP
MEI Pharma, Inc.
AwardDirectStock Option (Right to Buy)
20K shares- - Feb 14, 2025CLRB
Cellectar Biosciences, Inc.
AwardDirectStock option (right to buy)
60K shares- - Jan 2, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  LITS Lite Strategy, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Jul 7, 2026 |  CLRB Cellectar Biosciences, Inc. | Award Stock option (right to buy) | 25,000 | - | - | Direct |
| Nov 14, 2025 | LITS Lite Strategy, Inc. | Award Stock Option (Right to Buy) | 55,000 | - | - | Direct |
| Jul 15, 2025 |  MEIP MEI Pharma, Inc. | Award Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Feb 14, 2025 | CLRB Cellectar Biosciences, Inc. | Award Stock option (right to buy) | 60,000 | - | - | Direct |
| Jan 2, 2025 |  CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
1-6 of 6 transactions